137 related articles for article (PubMed ID: 36583462)
1. Off-label and compassionate use of targeted anticancer therapies: The experience of an Italian pediatric cancer center.
Cenna R; Basiricò M; Berchialla P; Bertorello N; Cagnazzo C; Ceolin V; De Luna E; Nolis C; Resente F; Fagioli F
Pediatr Blood Cancer; 2023 Mar; 70(3):e30148. PubMed ID: 36583462
[TBL] [Abstract][Full Text] [Related]
2. Measuring Safety and Outcomes for the Use of Compassionate and Off-Label Therapies for Children, Adolescents, and Young Adults With Cancer in the SACHA-France Study.
Berlanga P; Ndounga-Diakou LA; Aerts I; Corradini N; Ducassou S; Strullu M; de Carli E; André N; Entz-Werle N; Raimbault S; Roumy M; Renouard M; Gueguen G; Plantaz D; Reguerre Y; Cleirec M; Petit A; Puiseux C; Andry L; Klein S; Bodet D; Kanold J; Briandet C; Halfon-Domenech C; Nelken B; Piguet C; Saumet L; Chastagner P; Benadiba J; Millot F; Pluchart C; Schneider P; Thouvenin S; Gambart M; Serre J; Abbou S; Leruste A; Cayzac H; Gandemer V; Laghouati S; Vassal G
JAMA Netw Open; 2023 Jul; 6(7):e2321568. PubMed ID: 37399010
[TBL] [Abstract][Full Text] [Related]
3. Off-label prescribing of targeted anticancer therapy at a large pediatric cancer center.
Lim M; Shulman DS; Roberts H; Li A; Clymer J; Bona K; Al-Sayegh H; Ma C; DuBois SG
Cancer Med; 2020 Sep; 9(18):6658-6666. PubMed ID: 32750219
[TBL] [Abstract][Full Text] [Related]
4. Real-world treatment outcomes of medicines used in special situations (off-label and compassionate use) in oncology and hematology: A retrospective study from a comprehensive cancer institution.
Fontanals S; Esteve A; González A; Ibáñez C; Martínez J; Mesía R; Clopés A
Cancer Med; 2023 Aug; 12(16):17112-17125. PubMed ID: 37496404
[TBL] [Abstract][Full Text] [Related]
5. Systematic Data Monitoring and Analysis of Cardiovascular Off-label Prescriptions in Pediatrics: Focus on Angiotensin-Converting Enzyme Inhibitors (ACE-I) and Beta Blockers.
Cammarata SM; Capone G; Lombardi N; Pani L; Mugelli A
High Blood Press Cardiovasc Prev; 2022 Mar; 29(2):169-195. PubMed ID: 34997917
[TBL] [Abstract][Full Text] [Related]
6. Off-label use of anti-cancer drugs between clinical practice and research: the Italian experience.
Lerose R; Musto P; Aieta M; Papa C; Tartarone A
Eur J Clin Pharmacol; 2012 May; 68(5):505-12. PubMed ID: 22166932
[TBL] [Abstract][Full Text] [Related]
7. Safety and Efficacy of Off-label and Unlicensed Medicines in Children.
Lee JH; Byon HJ; Choi S; Jang YE; Kim EH; Kim JT; Kim HS
J Korean Med Sci; 2018 Sep; 33(37):e227. PubMed ID: 30190655
[TBL] [Abstract][Full Text] [Related]
8. An institutional audit of the use of novel drugs in pediatric oncology.
Lee J; Gillam L; Kouw S; McCarthy MC; Hansford JR
Cancer Rep (Hoboken); 2021 Dec; 4(6):e1404. PubMed ID: 33939320
[TBL] [Abstract][Full Text] [Related]
9. Off-label and unlicensed utilisation of medicines in a French paediatric hospital.
Joret-Descout P; Prot-Labarthe S; Brion F; Bataille J; Hartmann JF; Bourdon O
Int J Clin Pharm; 2015 Dec; 37(6):1222-7. PubMed ID: 26394784
[TBL] [Abstract][Full Text] [Related]
10. Drug utilization and off-label drug use in Spanish pediatric gastroenterology outpatients.
Ruíz-Antorán B; Piñeiro R; Avendaño C; Román E; Cilleruelo ML; Gutiérrez-Junquera C; Centeno G; Cilleruelo MJ
J Pediatr Gastroenterol Nutr; 2013 Feb; 56(2):173-7. PubMed ID: 23328455
[TBL] [Abstract][Full Text] [Related]
11. Off-label prescribing patterns of antiemetics in children: a multicenter study in Italy.
Zanon D; Gallelli L; Rovere F; Paparazzo R; Maximova N; Lazzerini M; Reale A; Corsetti T; Renna S; Emanueli T; Mannelli F; Manteghetti F; Da Dalt L; Palleria C; Banchieri N; Urbino A; Miglietta M; Cardoni G; Pompilio A; Arrighini A; Lazzari C; Messi G
Eur J Pediatr; 2013 Mar; 172(3):361-7. PubMed ID: 23207736
[TBL] [Abstract][Full Text] [Related]
12. Tolerance and efficacy of targeted therapies prescribed for off-label indications in refractory systemic autoimmune diseases: data of the first 100 patients enrolled in the TATA registry (TArgeted Therapy in Autoimmune Diseases).
Gottenberg JE; Chaudier A; Allenbach Y; Mekinian A; Amoura Z; Cacoub P; Cornec D; Hachulla E; Quartier P; Melki I; Richez C; Seror R; Terrier B; Devauchelle-Pensec V; Henry J; Gatfosse M; Bouillet L; Gaigneux E; Andre V; Baulier G; Saunier A; Desmurs M; Poulet A; Ete M; Bienvenu B; Truchetet ME; Michaud M; Larroche C; Dellal A; Leurs A; Ottaviani S; Nielly H; Vial G; Jaussaud R; Rouvière B; Jeandel PY; Guffroy A; Korganow AS; Jouvray M; Meyer A; Chatelus E; Sordet C; Felten R; Sibilia J; Litim-Ahmed-Yahia S; Kleinmann JF; Mariette X
RMD Open; 2022 Nov; 8(2):. PubMed ID: 36319066
[TBL] [Abstract][Full Text] [Related]
13. [Off-label use of psychotropic medications in pediatric wards: a prospective study].
Winterfeld U; Le Heuzey MF; Acquaviva E; Mouren MC; Brion F; Bourdon O
Arch Pediatr; 2009 Sep; 16(9):1252-60. PubMed ID: 19640689
[TBL] [Abstract][Full Text] [Related]
14. Off-label prescriptions in Italian hospices: a national survey.
Toscani F; Di Giulio P; Campi R; Pellerin I; De Luca A; Casale G;
J Pain Symptom Manage; 2009 Sep; 38(3):365-71. PubMed ID: 19564095
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and safety of compassionate use for rare diseases: a scoping review from 1991 to 2022.
Wu J; Yang Y; Yu J; Qiao L; Zuo W; Zhang B
Orphanet J Rare Dis; 2023 Nov; 18(1):368. PubMed ID: 38017575
[TBL] [Abstract][Full Text] [Related]
16. Off-label use of targeted therapies in osteosarcomas: data from the French registry OUTC'S (Observatoire de l'Utilisation des Thérapies Ciblées dans les Sarcomes).
Penel-Page M; Ray-Coquard I; Larcade J; Girodet M; Bouclier L; Rogasik M; Corradini N; Entz-Werle N; Brugieres L; Domont J; Lervat C; Piperno-Neumann S; Pacquement H; Bay JO; Gentet JC; Thyss A; Chaigneau L; Narciso B; Cornille H; Blay JY; Marec-Bérard P
BMC Cancer; 2015 Nov; 15():854. PubMed ID: 26541413
[TBL] [Abstract][Full Text] [Related]
17. Use and reimbursement of off-label drugs in pediatric anesthesia: the Italian experience.
Salvo I; Landoni G; Mucchetti M; Cabrini L; Pani L
Paediatr Anaesth; 2014 Jun; 24(6):625-31. PubMed ID: 24796404
[TBL] [Abstract][Full Text] [Related]
18. Respiratory drugs prescribed off-label among children in the outpatient clinics of a hospital in Malaysia.
Mohamad NF; Mhd Ali A; Mohamed Shah N
Int J Clin Pharm; 2015 Feb; 37(1):127-32. PubMed ID: 25488318
[TBL] [Abstract][Full Text] [Related]
19. [Off-label and unlicensed drug use: Results from a pilot study in a pediatric intensive care unit].
García-López I; Fuentes-Ríos JE; Manrique-Rodríguez S; M Fernández-Llamazares C
An Pediatr (Barc); 2017 Jan; 86(1):28-36. PubMed ID: 27151379
[TBL] [Abstract][Full Text] [Related]
20. Off-label drug use among hospitalised children: identifying areas with the highest need for research.
Hsien L; Breddemann A; Frobel AK; Heusch A; Schmidt KG; Läer S
Pharm World Sci; 2008 Oct; 30(5):497-502. PubMed ID: 18219585
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
